Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

10 results about "Lactate dehydrogenases" patented technology

Lactate dehydrogenase. lactate dehydrogenase n. Abbr. LDH Any of a class of enzymes that catalyze the reversible interconversion of pyruvate and lactate, found predominantly in the liver, kidneys, skeletal muscle, heart muscle, and red blood cells.

A lactate reactor capable of inhibiting intervertebral disc degeneration and a preparation method thereof

PendingCN122124218AOrganic active ingredientsPeptide/protein ingredientsMicrosphereAlanine aminotransferase
This invention discloses a lactate reactor capable of inhibiting intervertebral disc degeneration and its preparation method. The lactate reactor is an injectable gel microsphere loaded with lactate-catalyzing nanoparticles and matrix cell-derived factor SDF-1α. The lactate-catalyzing nanoparticles are mesoporous silica nanoparticles, whose mesopores are coated with lactate dehydrogenase, nicotinamide adenine dinucleotide, alanine aminotransferase, and glutamate, and whose surface is coated with an oxidized sodium alginate layer via a Schiff base reaction. This invention can efficiently convert pathological lactate in the nucleus pulposus microenvironment into alanine, which inhibits degeneration, while simultaneously recruiting stem cells to synergistically inhibit the process of intervertebral disc degeneration.
Owner:RUIJIN HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIV SCHOOL OF MEDICINE +1

Application of primrosein in the preparation of drugs for the treatment of liver fibrosis

ActiveCN116077475BOrganic active ingredientsDigestive systemHepatic stellate cell activationLiver fibrosis
This invention discloses the application of primrosein in the preparation of drugs for the treatment of liver fibrosis. The chemical name of primrosein is 2-methoxy-6-pentyl-1,4-benzoquinone, and its molecular formula is C2. 12 O3H 16 Cellular experiments showed that primrosein reduced the proliferative activity of hepatic stellate cells but did not increase the release of lactate dehydrogenase from hepatic stellate cells, and had no significant inhibitory effect on hepatocyte proliferation. Animal experiments showed that primrosein reduced serum levels of markers in carbon tetrachloride-induced liver fibrosis model mice, decreased collagen fiber content in their liver tissue, and inhibited the expression of hepatic stellate cell activation markers, demonstrating excellent anti-liver fibrosis effects. This indicates that primrosein can be used to prepare effective drugs for the treatment of liver fibrosis.
Owner:NANTONG UNIV

A recombinant saccharomyces cerevisiae and its construction method and application

The present application relates to the technical field of bioengineering, and particularly relates to a recombinant Saccharomyces cerevisiae and a construction method and application thereof, comprising the following steps: step one, using the whole genome of Enterococcus faecalis as a template, a recombinant strain SC1-1 is constructed; step two, using the recombinant strain SC1-1 as a primary strain, L-lactate dehydrogenase CYB2 gene of Saccharomyces cerevisiae is knocked out to obtain a recombinant strain SC2; step three, using the recombinant strain SC2 as a primary strain, branched-chain-2-oxo acid decarboxylase THI3 gene of Saccharomyces cerevisiae is knocked out to obtain a recombinant strain SC3; step four, using the whole genome of Saccharomyces cerevisiae as a template, a recombinant strain SC4 is constructed. The present application innovatively optimizes the source of L-lactate dehydrogenase L-LDH, knocks out L-lactate dehydrogenase CYB2 and branched-chain-2-oxo acid decarboxylase THI3, overexpresses pyruvate kinase CDC19 and H(+)-ATPase PMA2, and makes the L-lactic acid production of Saccharomyces cerevisiae increase to 33.45 g / L.
Owner:ANHUI POLYTECHNIC UNIV

Albumin nanoparticle co-loading with menadione and lactate oxidase, preparation method and application

PendingCN122124263AOrganic active ingredientsPeptide/protein ingredientsLactate clearanceLactate oxidase
This invention discloses albumin nanoparticles co-loaded with flavin and lactate oxidase, their preparation method, and applications. Using human serum albumin as a carrier, flavin and lactate oxidase are simultaneously encapsulated at a mass ratio of 10:1, with a particle size of 150-180 nm and a polydispersity index of less than 0.2. This invention exerts its anti-hepatocellular carcinoma effect through mechanisms such as reducing lactate levels in the tumor microenvironment, inducing an increase in reactive oxygen species, inhibiting cGAS protein lactation modification, and activating the cGAS-STING signaling pathway. The nanoparticles exhibit high encapsulation efficiency and good stability. The flavin loaded on these nanoparticles can significantly reduce the reduction of pyruvate to lactate by inhibiting lactate dehydrogenase; simultaneously, the lactate oxidase loaded on these nanoparticles catalyzes the dehydrogenation of lactate to pyruvate. In other words, these nanoparticles synergistically regulate lactate metabolism through a two-way regulatory strategy of "reducing source and increasing sink"—"inhibiting lactate production" and "promoting lactate clearance"—significantly enhancing in vitro and in vivo anti-tumor effects, and demonstrating high biosafety.
Owner:HUNAN ACAD OF CHINESE MEDICINE +1

Preparation method of active lactobacillus and application thereof in livestock and poultry feed

PendingCN122423608ABiotechnologyMetabolite
The application discloses a preparation method of active lactobacillus and application of the active lactobacillus in livestock and poultry feed, and comprises the following steps: S1, inoculating a strain; S2, fermentation culture; and S3, preparing active lactobacillus powder; the application significantly improves the production efficiency and product stability of the active lactobacillus by optimizing the culture medium formula and fermentation process parameters; the soybean meal hydrolysate and corn starch hydrolysis sugar are used as a composite carbon and nitrogen source, and the polysorbate 80 is used to improve the surface permeability of the bacterial body, so that the lactobacillus plantarum can rapidly proliferate in a low-cost culture medium, and a foundation is laid for efficient synthesis of bacteriocin; fumaric acid is used to inhibit the activity of lactate dehydrogenase, metabolic flow is directed to the bacteriocin synthesis path, the accumulation amount of lactic acid is effectively reduced, and the feedback inhibition of the acid metabolite on the bacterial body is avoided; the prepared active lactobacillus powder has excellent thermal stability, and realizes long-acting stability of the antibacterial effect of the feed.
Owner:XIAN RUOHAN BIOLOGICAL FEED CO LTD

Physiological age prediction model based on physical examination indicators and its application

PendingCN122369901AAcyl CoA dehydrogenaseKidney Glomerulus
This invention provides a physiological age prediction model that predicts the physiological age of a subject by detecting physical examination indicators. These indicators include measurements of blood cells, glucose metabolism, tumor markers, urine components, anthropometric measurements, lipids, blood components, and tissue function. Preferably, these indicators include one or more selected from the following: glomerular filtration rate (eGFR), cystatin C, serum creatinine (SCr), blood urea nitrogen (BUN), timed up and go, light reaction time, fasting blood glucose (FBG), insulin-like growth factor (IGF), superoxide dismutase (SOD), insulin (INS), albumin (Alb), alkaline phosphatase (ALP), folic acid, lactate dehydrogenase (LDH), aspartate aminotransferase (AST), and high-sensitivity C-reactive protein (hs-CRP). More preferably, all of the aforementioned physical examination indicators are included. This invention also provides a physiological age prediction device applying the above-mentioned physiological age prediction model and a computer storage medium.
Owner:BEIJING HOSPITAL

He-tian summer apple beverage, and preparation method and application thereof

PendingCN122321044ABiotechnologyApple extract
This invention discloses a Hotan summer apple beverage, its preparation method, and its application, belonging to the field of pharmaceutical technology. The Hotan summer apple beverage of this invention comprises the following components, by weight: 500-1000 parts Hotan summer apple extract, 100-200 parts Hotan red grape extract, 1-2 parts Hotan rose, 0.1-0.5 parts saffron, and 20-60 parts flavoring agent. This Hotan summer apple beverage of this invention can significantly increase the proliferation level of H9C2 cells damaged by oxygen-glucose deprivation, and significantly decrease the expression of the serum myocardial injury marker lactate dehydrogenase (LDH), indicating that the beverage of this invention has a protective effect on cardiomyocytes. Compared with the commonly used inhibitor Acetylcysteine, this Hotan summer apple beverage of this invention is made from ingredients that are both food and medicine, with no side effects from long-term use, making it more suitable for long-term use by patients with chronic diseases. The materials in this beverage are Hotan summer apple, Hotan red grape, Hotan rose, and saffron, which are products of large-scale cultivation, with high yield and low cost. The preparation process is simple, reducing the cost of medication.
Owner:XINJIANG HOTAN UNIVERSITY

Application of momordica grosvenori sweet glycoside extract in improving the reproductive capacity of heat-stressed boars

PendingCN122097443AAnimal feeding stuffAccessory food factorsPhysiologyPig reproduction
The Mogroside extract has the effect of improving the damage of the heat stress boar's reproductive capacity. Research shows that, in the process of heat stress of boar, by adding Mogroside extract in the basic diet, the damage of reproductive capacity caused by heat stress can be effectively improved. The test data shows that the Mogroside extract can significantly improve the sperm density, effective sperm number, sperm motility and reduce the sperm abnormality rate of boar; significantly increase the content of a-glucosidase, lactate dehydrogenase, acrosome enzyme and hyaluronidase in the semen, and increase the concentration of testosterone in the serum, enhance the energy supply, structural integrity, functional maturity and fertilization capacity of sperm. Therefore, the Mogroside extract has the potential for further development in the treatment and prevention of heat stress boar's reproductive capacity damage, and can be used for preparing the medicine for improving the heat stress boar's reproductive capacity, so as to further develop the health care function and medicinal value of Siraitia grosvenorii.
Owner:GUANGXI UNIV